Scheijmans, Jochem C. G.
,
Borgstein, Alexander B. J.
Puylaert, Carl A. J.
Bom, Wouter J.
Bachiri, Said
van Bodegraven, Eduard A.
Brandsma, Amarins T. A.
ter Brugge, Floor M.
de Castro, Steve M. M.
Couvreur, Roy
Franken, Lotte C.
Gaspersz, Marcia P.
de Graaff, Michelle R.
Groenen, Hannah
Kleipool, Suzanne C.
Kuypers, Toon J. L.
Martens, Milou H.
Mens, David M.
Orsini, Ricardo G.
Reneerkens, Nando J. M. M.
Schok, Thomas
Sedee, Wouter J. A.
Tavakoli Rad, Shahzad
Volders, José H.
Weeder, Pepijn D.
Prins, Jan M.
Gietema, Hester A.
Stoker, Jaap
Gisbertz, Suzanne S.
Besselink, Marc G. H.
Boermeester, Marja A.
Article History
Received: 15 February 2021
Accepted: 23 April 2021
First Online: 12 May 2021
Declarations
:
: This study was conducted at 21 Dutch Hospitals in accordance with Good Clinical Practice (Declaration of Helsinki 2002). Granted permission from the hospital authorities to access the data by local researchers was obtained. Ethical approval was waived by a central institutional review board because of the observational nature of the study (Medical Research Ethics Committee, Academic Medical Center Amsterdam). All patients were informed by information letters, informed consent was obtained through an opt-out procedure, as was customary for COVID-19 related observational research.
: Informed consent for publication was obtained through an opt-out procedure, as was customary for COVID-19 related observational research.
: The authors declare that they have no competing interests. Professor Boermeester reported receiving institutional grants from J&J/Ethicon, KCI/3 M, Bard and New Compliance; and being an advisory board member and/or speaker and/or instructor for KCI/3 M, J&J/Ethicon, Allergan, Bard, Gore, Smith & Nephew. No funding was received for current study.